Zovato, S <br/><br/>
Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL).  [electronic resource] 

 -  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  May 2012 
 - 411-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1439-4286 
<br/><br/><label>Standard No.: </label>10.1055/s-0032-1311637  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Female<br/>Head and Neck Neoplasms--radiotherapy<br/>Humans<br/>Mediastinal Neoplasms--radiotherapy<br/>Octreotide--analogs & derivatives<br/>Organometallic Compounds--therapeutic use<br/>Paraganglioma--radiotherapy<br/>Receptors, Peptide--therapeutic use